与运动增多性运动障碍及共济失调相关疾病中的[18F]FDG PET:一项系统综述
该研究遵循PRISMA指南系统检索至2021年11月的文献,最终纳入104篇,涵盖舞蹈症、共济失调、肌张力障碍、震颤、代谢病、肌阵挛、抽动及自身免疫性疾病;发现各运动障碍存在多个脑区糖代谢改变,部分临床特征与糖代谢相关,震颤、共济失调和舞蹈症治疗后[18F]FDG PET代谢改变可正常化。
要点
- 肌张力障碍表现为豆状核代谢增高及小脑代谢增高或减低。
- 共济失调表现为明显小脑代谢减低,舞蹈症表现为纹状体代谢减低。
- 震颤、共济失调和舞蹈症治疗后[18F]FDG PET代谢改变可正常化。
核心结论
- 在所有运动增多性运动障碍相关疾病中,多个部分重叠的脑区存在代谢减低或增高,临床特征常与糖代谢相关。
- 对某些运动障碍,[18F]FDG PET代谢改变反映了治疗效果。
研究设计与样本
- 遵循PRISMA指南进行系统文献检索,PubMed检索截至2021年11月。
- 初检获1240篇文献,最终纳入104篇。
- 纳入研究涉及震颤、抽动、肌张力障碍、共济失调、舞蹈症、肌阵挛、功能性运动障碍或自身免疫/代谢性病因所致混合性运动障碍。
- 纳入文献中舞蹈症27篇、共济失调25篇、肌张力障碍20篇、震颤8篇、代谢病7篇、肌阵挛6篇、抽动6篇、自身免疫性疾病5篇。
- 未纳入功能性运动障碍相关论文。
主要发现
- 肌张力障碍表现为豆状核代谢增高及小脑代谢增高或减低。
- 共济失调表现为明显小脑代谢减低,舞蹈症(以亨廷顿病为主)表现为纹状体代谢减低。
- 临床特征与糖代谢之间的相关性常被描述。
- 震颤、共济失调和舞蹈症治疗后[18F]FDG PET显示代谢改变正常化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To give a comprehensive literature overview of alterations in regional cerebral glucose metabolism, measured using [18F]FDG PET, in conditions associated with hyperkinetic movement disorders and ataxia. In addition, correlations between glucose metabolism and clinical variables as well as the effect of treatment on glucose metabolism are discussed. METHODS: A systematic literature search was performed according to PRISMA guidelines. Studies concerning tremors, tics, dystonia, ataxia, chorea, myoclonus, functional movement disorders, or mixed movement disorders due to autoimmune or metabolic aetiologies were eligible for inclusion. A PubMed search was performed up to November 2021. RESULTS: Of 1240 studies retrieved in the original search, 104 articles were included. Most articles concerned patients with chorea (n = 27), followed by ataxia (n = 25), dystonia (n = 20), tremor (n = 8), metabolic disease (n = 7), myoclonus (n = 6), tics (n = 6), and autoimmune disorders (n = 5). No papers on functional movement disorders were included. Altered glucose metabolism was detected in various brain regions in all movement disorders, with dystonia-related hypermetabolism of the lentiform nuclei and both hyper- and hypometabolism of the cerebellum; pronounced cerebellar hypometabolism in ataxia; and striatal hypometabolism in chorea (dominated by Huntington disease). Correlations between clinical characteristics and glucose metabolism were often described. [18F]FDG PET-showed normalization of metabolic alterations after treatment in tremors, ataxia, and chorea. CONCLUSION: In all conditions with hyperkinetic movement disorders, hypo- or hypermetabolism was found in multiple, partly overlapping brain regions, and clinical characteristics often correlated with glucose metabolism. For some movement disorders, [18F]FDG PET metabolic changes reflected the effect of treatment.
引用
- Timmers ER, Klamer MR, Marapin RS, et al. [18F]FDG PET in conditions associated with hyperkinetic movement disorders and ataxia: a systematic review. Eur J Nucl Med Mol Imaging. 2023. PMID: 36702928. doi:10.1007/s00259-023-06110-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。